Ambu Forever ForwardShare informationAnnual key figuresQuarterly resultsOwnershipShare CapitalDividend PolicyAnalystsConsensus estimates searchmenu Ambu Forever ForwardclosesearchEndoscopykeyboard_arrow_downcloseSINGLE-USE ENDOSCOPYPulmonologyBronchoscopesVideo LaryngoscopesDisplaying UnitsProductsOfstead webinaraScope 4 Broncho Guys studyProceduresIntubationOne Lung VentilationSecretion ManagementBAL & BWBedside PDTTrainingKnowledgeaScope 5 Broncho benefitsBronchoscopy solution for ICUClinical EvidenceAmbu® aScope™EAR, NOSE, THROAT (ENT)RhinolaryngoscopesDisplaying UnitsProductsProceduresFlexible laryngoscopyIn-office biopsySwallowing assessmentsKnowledge7 ways for single-useSingle-use rhinolaryngoscope comparisonSimplify bedside swallowing assessmentsClinical EvidenceGastroenterologyDuodenoscopeGastroscopeDisplaying UnitsProductsKnowledge7 key advantages of a large working channelSingle-use gastroscope benefitsClinical insightsAmbu single-use gastroscopesClinical videosTests and evaluationsTestimonialsOne-page clinical case reportsWhite papersAmbu single-use duodenoscopeClinical videosTestimonialsOne-page clinical case reportsWhite papersUrologyCystoscopesUreteroscopesDisplaying UnitsProductsKnowledgeSingle-use cystoscopy benefitsCost-comparison in urologyQualities of effective ureteroscopesNeurologykeyboard_arrow_downclosePatient monitoring and diagnosticsNeurologyEEG ElectrodesEMG ElectrodesEMG Guided InjectionsIntraoperative MonitoringProductsStop cross contaminationClinical EvidenceAmbu® Neuroline EEG CupAmbu® Neuroline EMG NeedlesAmbu® Neuroline Surface ElectrodesCardiologykeyboard_arrow_downclosePatient monitoring and diagnosticsCardiologyECG ElectrodesProductsClinical EvidenceAmbu® BlueSensor ECG ElectrodesAmbu® WhiteSensor ECG ElectrodesAirway Management & Anaesthesiakeyboard_arrow_downcloseAirway Management and AnaesthesiaBronchoscopesVideo LaryngoscopesDouble Lumen TubesSingle Lumen TubesEndobronchial BlockersLaryngeal MasksFace MasksBreathing BagsResuscitatorsProductsVivaSight-DL Cost EffectivenessDownload summaryClinical EvidenceAmbu® AuraGain™Ambu® Aura-i™Ambu® AuraOnce™Ambu® AuraFlex™Ambu® Aura40™King Vision® Video LaryngoscopeAmbu® VivaSight™ 2 DLTAmbu® VivaSight™ 2 SLTAmbu® Face MasksKnowledge5 benefits of a connected airway platformAnaesthetist workspace studiesEmergency Care & Trainingkeyboard_arrow_downcloseEmergency Care and TrainingResuscitatorsExtrication CollarsVideo LaryngoscopesALS Training ManikinsBLS Training ManikinsProductsTopicsOur iconic Ambu bagClinical EvidenceAmbu® ResuscitatorsAmbu® Military Mark lllAmbu® SPUR® IIAmbu® PEEP ValvesAmbu® ManikinssearchAmbu Forever ForwardNewsletterSustainabilitykeyboard_arrow_downSustainability approachESG portalInvestorsCareerMediaAboutkeyboard_arrow_downOur CompanyOur historyTop managementOur strategyBusiness Ethics and ComplianceReporting and PoliciesNewsContactkeyboard_arrow_downAmbu AddressesLocal DistributorsContact usResearch SupportpublicAmbu GlobalCorporate WebsiteEuropeAmericas and Asia Pacific InvestorsNewskeyboard_arrow_downNews from AmbuSign upReportskeyboard_arrow_downReports in EnglishReports in DanishPresentationskeyboard_arrow_downInvestor presentationsRecent webcastsCapital Markets DaysCalendarShare Infokeyboard_arrow_downShare informationAnnual key figuresQuarterly resultsOwnershipShare CapitalDividend PolicyAnalystsConsensus estimatesGovernancekeyboard_arrow_downCorporate GovernanceAnnual General MeetingInvestor Relations PolicyArticles of AssociationTwo share classesManagementBoard of DirectorsInvestor Relations Contact
InvestorsNewskeyboard_arrow_downNews from AmbuSign upReportskeyboard_arrow_downReports in EnglishReports in DanishPresentationskeyboard_arrow_downInvestor presentationsRecent webcastsCapital Markets DaysCalendarShare Infokeyboard_arrow_downShare informationAnnual key figuresQuarterly resultsOwnershipShare CapitalDividend PolicyAnalystsConsensus estimatesGovernancekeyboard_arrow_downCorporate GovernanceAnnual General MeetingInvestor Relations PolicyArticles of AssociationTwo share classesManagementBoard of DirectorsInvestor Relations ContactQ4, FY 2023/24 and FY 2024/25 consensus estimatesEstimates for Q4 and FY 2023/24 and FY 2024/25 based on the average.30 October 2024
